DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+12.56%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$53.7B
AUM Growth
+$4.94B
(+10%)
Cap. Flow
+$249M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
26.8%
Holding
1,542
New
66
Increased
528
Reduced
500
Closed
103
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$166M |
| 2 |
Verizon
VZ
|
+$145M |
| 3 |
KLA
KLAC
|
+$124M |
| 4 |
Dell
DELL
|
+$114M |
| 5 |
Apple
AAPL
|
+$110M |
Top Sells
| 1 |
XRTX
XORTX Therapeutics
XRTX
|
+$161M |
| 2 |
NVIDIA
NVDA
|
+$108M |
| 3 |
L3Harris
LHX
|
+$104M |
| 4 |
Voya Financial
VOYA
|
+$103M |
| 5 |
Micron Technology
MU
|
+$102M |
Sector Composition
| 1 | Technology | 29.61% |
| 2 | Healthcare | 16.46% |
| 3 | Financials | 10.3% |
| 4 | Industrials | 9.8% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
ANI Pharmaceuticals
ANIP
$2.11B
| $1.57M | ﹤0.01% |
23,022
| – | – |
|
802
Southwest Airlines
LUV
$16.3B
| $1.56M | ﹤0.01% |
54,048
-2,657
| -5% | -$76.8K |
|
803
Bath & Body Works
BBWI
$5.81B
| $1.56M | ﹤0.01% |
31,797
+322
| +1% | +$15.8K |
|
804
Ovintiv
OVV
$11B
| $1.56M | ﹤0.01% |
30,518
-49,327
| -62% | -$2.52M |
|
805
Alamos Gold
AGI
$13.9B
| $1.53M | ﹤0.01% |
105,000
+45,614
| +77% | +$664K |
|
806
Fortrea Holdings
FTRE
$909M
| $1.5M | ﹤0.01% |
38,219
-15,871
| -29% | -$624K |
|
807
Avidity Biosciences
RNA
$5.97B
| $1.48M | ﹤0.01% |
60,000
| – | – |
|
808
Dynatrace
DT
$14.4B
| $1.47M | ﹤0.01% |
31,407
-52,165
| -62% | -$2.44M |
|
809
Virtu Financial
VIRT
$3.27B
| $1.45M | ﹤0.01% |
72,229
-26,206
| -27% | -$527K |
|
810
TechnipFMC
FTI
$16.8B
| $1.45M | ﹤0.01% |
58,000
| – | – |
|
811
Edgewise Therapeutics
EWTX
$1.55B
| $1.44M | ﹤0.01% |
80,000
| – | – |
|
812
Repligen
RGEN
$6.76B
| $1.42M | ﹤0.01% |
7,750
-284
| -4% | -$52K |
|
813
HEICO
HEI
$44.1B
| $1.41M | ﹤0.01% |
7,341
+3,855
| +111% | +$743K |
|
814
Arcturus Therapeutics
ARCT
$489M
| $1.41M | ﹤0.01% |
43,889
| – | – |
|
815
Iovance Biotherapeutics
IOVA
$861M
| $1.4M | ﹤0.01% |
100,000
| – | – |
|
816
Vail Resorts
MTN
$5.37B
| $1.38M | ﹤0.01% |
6,370
-10,640
| -63% | -$2.3M |
|
817
Annaly Capital Management
NLY
$14.2B
| $1.38M | ﹤0.01% |
70,717
+791
| +1% | +$15.4K |
|
818
Insmed
INSM
$30.8B
| $1.36M | ﹤0.01% |
50,000
| – | – |
|
819
Vaxcyte
PCVX
$4.15B
| $1.36M | ﹤0.01% |
20,000
| – | – |
|
820
Clearway Energy Class C
CWEN
$3.35B
| $1.35M | ﹤0.01% |
60,669
-40,524
| -40% | -$900K |
|
821
Arcutis Biotherapeutics
ARQT
$2.11B
| $1.34M | ﹤0.01% |
140,000
| – | – |
|
822
DraftKings
DKNG
$22.7B
| $1.34M | ﹤0.01% |
28,825
+1,195
| +4% | +$55.4K |
|
|
NTST
823
NETSTREIT Corp
NTST
$1.75B
| $1.33M | ﹤0.01% |
75,155
+58,201
| +343% | +$1.03M |
|
824
Denali Therapeutics
DNLI
$2.14B
| $1.32M | ﹤0.01% |
64,210
| – | – |
|
825
Dayforce
DAY
$10.9B
| $1.3M | ﹤0.01% |
19,788
-400
| -2% | -$26.4K |
|